JAMP Pharma Corp. says it’s recalling one lot of JAMP-Pregabalin ache medicine as a result of some bottles labelled to include 50-milligram capsules could include 150-milligram capsules as a substitute.
The mislabelled product may result in sufferers receiving a a lot bigger dose than prescribed, which may lead to an overdose and “pose severe, doubtlessly deadly well being dangers,” Well being Canada stated in a public advisory.
JAMP-Pregabalin is a prescription drug utilized in adults to deal with ache brought on by nerve injury on account of diabetes, shingles or spinal twine damage, in addition to ache related to fibromyalgia.
Signs of pregabalin overdose could embody sudden temper modifications, sleepiness, confusion, melancholy, agitation, restlessness and seizures, the regulator stated on Saturday.
Taking an excessive amount of pregabalin whereas taking medication that act on the central nervous system, together with opioids, has been related to coronary heart electrical issues, seizures and demise.
Well being Canada stated in case you are experiencing signs of an overdose then search speedy medical consideration.
Sufferers mustn’t abruptly cease taking pregabalin, as this will likely lead to withdrawal signs together with insomnia, nausea, headache, nervousness, extreme sweating, diarrhea, and convulsions.
For those who’ve been prescribed 50-milligram capsules and the bottle accommodates the upper dose, or in case you are unusure, return it to your pharamacy, Well being Canada suggested. In case you are unable to return your capsules to the pharmacy immediately, discuss to your pharmacist or physician for additional steerage.
The product was distributed nationally.
Source link